H
ereditary hemochromatosis (HH) 1, an autosomal recessive, HLA-linked disease, is one of the most common genetic disorders in man. It is characterized by a failure in regulation of iron absorption, an increase of transferrin saturation, and progressive iron deposition predominantly in the parenchymal cells of several organs (1) . Increased iron absorption in HH homozygotes leads to accumulation of iron, with eventual tissue damage and organ dysfunction. When the disorder remains untreated, premature mortality resulting from hepatocellular carcinoma, cirrhosis, cardiomyopathy, or diabetes mellitus is common (2, 3) . Removal of iron and the prevention of its reaccumulation by phlebotomy treatment dramatically improves life expectancy in these patients (4) (5) (6) (7) . The discovery of a tight linkage between HH and the HLA-A locus has led to the clarification of the genetic nature and the autosomal recessive inheritance of the disease (8, 9) . A similar disease is not known in animals, and although many attempts have been made to develop an appropriate animal model by dietary application of different iron compounds, severe organ damage as seen in HH could not be reproduced in these models (10) .
1Abbreviations used in this paper. [32m, [32-rmcroglobuhn; [32m /% 132m knockout (mice); Hb, hemoglobin; HCT, hematocnt; HH, hereditary hemachromatosls; IR, iron retention; MCV, mean corpuscular volume; MT, mucosal transfer fraction of iron; MU, mucosal uptake of iron; RE, reticuloendothehal; TIBC, total iron-binding capacity; TS, transfernn saturation.
In a previous study, we have revealed the existence of hepatic iron overload in [32-microglobulin ([32m) -deficient mice similar to that found in HH (11, 12) . This was based on a histological and quantitative study of the steady-state iron distribution and content in tissues of [32m -/-mice. These results were confirmed more recently by others (13) . In addition, the latter study demonstrated that increased levels of dietary iron led to accelerated iron accumulation, and reported an increased incidence ofhepatocellular carcinoma in 132m knockout mice. Such carcinomas are frequently seen in HH patients.
In this report, we characterize the nature of the iron metabolism defect found in [32m -/-mice. [32m is required for the normal surface expression of classical and nonclassical MHC class I molecules (14, 15) . Thus, mice lacking a functional [32m gene fail to express MHC class I products (16, 17) . Such mice lack CD8 + lymphocytes. To analyze a possible involvement of CD8 + cells, we also analyzed iron metabofism in CD8 -/-mice. Mice that are mutant in the TAP-1 peptide transporter do not express classical class I molecules on the surface of their cells (18) . Some nonclassical MHC-I molecules can be expressed independently of TAP function, however (19, 20) . Therefore, to extend our analysis of the nature of the [32m-dependent molecules involved in iron metabolism, we included the TAP1-/-mice in our study. [32m -/-mice failed to reduce intestinal iron absorption in the face of iron overload and had abnormally high (>80%) values of transferrin saturation. This defect was specific for 132m -/-mice, since the iron status of TAP1 -/-mice and CD8 -/-mice was comparable to that of controls. Additional results are presented that suggest that the iron metabolism in 132m -/-mice is affected at the level of the gut mucosa, as well as at the level of iron storage in Kupffer cells.
The results presented here reveal a remarkable similarity between iron metabolism in ~32m -/-mice and in HH patients, and support the unexpected involvement of MHC class I-like molecule(s) in the regulation of iron homeostasis.
Materials and Methods
Mice. C57BL/6 (B6) female mice aged 6-8 wk were purchased from IFFA Credo (Brussels, Belgium), and used as controls. The f32-rmcroglobulin "knockout" (132m -/-) mice (16) were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA) and further bred in our animal facility; CD8 /-lmce (21) were obtained from Dr. T. Mak (University of Toronto, Toronto, Canada), and further bred in our animal facility. Both mutant mice had been back-crossed onto the C57BL/6 background. Liver samples from TAP-/-mice (18) were obtained from Dr. S. Tonegawa (Massachusetts Institute of Technology, Cambridge). All animals were given a commercial diet (RMH-B®; Hope Farms, Woerden, The Netherlands) or, when indicated, an iron-enriched diet containing 2.5% (wt/wt) carbonyl iron (Sigma Immunochermcals, St. Louis, MO) for 14 d.
For all animal experiments, wntten consent was obtained from the local Animal Experiments Committee of Utrecht University (Utrecht, The Netherlands).
Transferrin Saturation and Hematological Measurements. Heparinized blood was obtained by orbital puncture under diethylether anesthesia. Hemoglobin (Hb), hematocrit (HCT), and mean corpuscular volume (MCV) were determined using a Coulter-S counter (Coulter Electronics, Hialeah, FL). Plasma iron and total ironbinding capacity (TIBC) were determined by the Ferrozine method (Iron FZ Test; Roche, Basel, Switzerland) with the CO-BAS-BIO autoanalyzer (Hoffman-La Roche BV, Mijdrecht, The Netherlands). Transferrin saturation (TS) was calculated from the TIBC and plasma iron values.
Histology. Samples of liver, spleen, kidney, heart, and pancreas were fixed in 4% buffered formaldehyde. After routine histology processing, the paraffin sections were stained by hematoxyhn and eosm. For the detection of ferric iron (Fe3+), the Prussian blue stain was used (22) .
Measurement of Liver Iron Concentration. Liver samples were weighed wet, then dried overnight at 106°C and weighed again. The dned samples were ashed in an oven at 500°C for 17 h, then fully solubihzed in 6 M HC1, and the final solution was adjusted with demineralized water to a final HC1 concentration of 1.2 M. Iron concentration of the samples was determined by flame atomic absorption spectrometry (Varian SpectrAA 250 Plus; Varian, Mulgrave, Victoria, Austraha).
Electron Microscopy. Small pieces of liver were fixed in a modified Karnovsky fixative consisting of 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M Na-cacodylate buffer, supplemented with 2 mM CaCI 2, for at least 24 h at 4°C. The tissue was washed twice with the same buffer, postfixed in 1% OsO4, and embedded in Epon 812. 1-mm semithin sections were stained with methylene blue and pararosanilin (23) . Ultrathin sections (60 nm) were cut and contrasted with 3% uranyl magnesium acetate for 45 rain at 63°C followed by Reynolds' lead citrate for 10 min. Stained and unstained sections were viewed in an electron microscope (201c; Philips Technologies, Chesire, CT).
Gastrointestinal Iron Absorption. For iron absorption tests, the mice were fasted for 6 h and housed for 3 d in cages equipped with grates to minimize coprophagy.
All test doses were freshly prepared and were administered in aqueous solution using demineralized water. SgFe(III) citrate was added to Fe(II) as ferrous sulfate and a 20X molar excess of 1-ascorbic acid solution to reduce the Fe(III). SlCrC13 was added as a nonabsorbable indicator. The total amount of Fe(II) per test dose was 5 ~g per mouse and had a final volume of 0.3 ml. Each mouse received °°50 kBq of SgFe and 200 kBq of SlCr.
The test dose was orally applied with the use of an olive-tipped oroesophageal needle. Total body radioactivity was measured with a whole-body gamma counter (Automatic Scanner DS4/4S; Tracelab Ltd., Weybridge, Surrey, UK) with separate detection windows tbr 5VFe and SlCr peaks. The values were corrected for radioisotope decay and day-to-day fluctuations of the scanner with the use of a radium source. The SlCr peaks were corrected for the Compton effect of SgFe.
Mucosal uptake of iron (MU) was calculated from the activity of 59Fe and SlCr administrated (measured immediately after test dose administration and considered as 100%), as well as from the activity of 59Fe (F1) and SlCr (C1) found within the body 22 h later, using the formula MU = 100 X (F1 -C1)/(100 -C1)%. F1 and C1 were expressed as the percentage of the amount of SgFe andSlCr administered. 59Fe retention (IR) was determined by whole-body counting 7 d after administration of the test dose. The mucosal transfer fraction of iron (MT) was determined as the ratio IR/MU.
When the animals were tested twice for iron absorption, the second test dose was administered 16 d after the first dose. Background values of the first test dose were corrected for radioisotope decay.
Fetal Liver Cell Transfer. Recipient animals were lethaly irradiated (9.5 Gy) and reconstituted with 5-10 X 106 day 13 fetal liver cells by intravenous injection. Chimeras were kdled at 4, 8, and 12 wk after reconstitutlon, and chimerism was monitored by FACS ® (Becton Dickinson, Mountain View, CA) using CD4, CD8 (PharMingen, San Diego, CA), and H141.31.10 (anti-K b) antibodies.
Statistical Analysis. Results are presented as the mean + SD. Student's t test was used for comparison between the control and knockout mouse groups. For individual comparisons between two measurements, the paired t test was used. The level of sigmflcance was preset at P <0.05.
Results
Increased Plasma Iron and TS in ~2rn /-Mice. Under norreal circumstances, the vast majority of plasma iron is bound to transferfin. Transferrin-bound iron is transported to various sites of utilization, where it is delivered to cells via transferrin receptors (24) . In HH homozygotes, the earliest laboratory abnormalities are elevated plasma iron concentrations and increased TS (25, 26) . Therefore, we measured plasma iron and TIBC, and calculated transferrin saturation from that in 2-and 12-too-old mice. At both ages, f32m -/-mice had persistently higher plasma iron concentrations ( Fig. 1 A) and TS ( Fig. 1 B) than either B6 or CD8 -/-control mice. 
Increased iron Concentrations in Livers from fl2m -/ -Mice.
Diagnosis o f iron storage disease n o r m a l l y requires a biopsy o f the liver, the m a j o r o r g a n for excess iron storage (1) . and TAP1 /-mice were comparable to B6 control mice ( Fig. 1 C) . Similar observations were made at 12 mo of age, when [32m -/-mice had accumulated about three times more iron in their livers than age-matched B6, CD8 -/-, or TAP1 -/-mice ( Fig. 1 C) .
Celhdar Distribution of Storage Iron in Livers.
One of the distinguishing features of the pathology in HH in humans is that the initial deposition of iron is predominantly in the parenchymal cells of affected tissues, with insignificant early involvement of macrophages of the reticuloendothelial system (27) . No detectable iron was seen histologically in B6 (Fig. 2 A) , CD8 / , and TAP1-/-mice (not shown) of various ages that were fed with a standard diet. Prussian blue staining of hver sections from >50 [32m -/-rmce revealed a predominant presence of iron in parenchymal cells (Fig. 2  B) , confirming the finding reported earlier (11, 13) . At early stages, the iron-loaded hepatocytes were concentrated in periportal areas, but later they were distributed equally throughout all areas of the liver lobule. In older animals, iron depositions were also present in the pancreas, kidneys, and heart (not shown). Two out of seven 1-yr-old [32m -/-mice had a sevenfold increase in liver iron concentrations (Fig. 1 C) and had developed hepatic fibrosis (not shown), which was never seen in control mice of the same age. Examination of livers from [32m -/ mice by electron microscopy revealed electron-dense lysosomal structures in hepatic parenchymal cells located in periportal areas. These lysosomes had a granular substructure (Fig. 3 A) and, in unstained sections, they were composed of more or less densely packed ferritin granules. Significant amounts offerritln granules were also present in the cytoplasm of hepatic parenchymal cells (Fig. 3 B) . Of interest, lysosomal deposits of ferritin and hemosiderin are prominent in the hepatocytes of patients with HH.
To study the effects of iron overloading on the iron storage in the liver, animals were fed a diet supplemented with 2.5% (wt/wt) ofcarbonyl-iron for 14 d. In B6 and CD8 -/-mice, iron deposition was present in hepatocytes, but was particularly prominent in Kupffer cells (Fig. 2 C) . In contrast, in dietary iron-loaded [32m -/-mice, the iron continued to be found predominantly in parenchymal cells (Fig. 2 D) .
Erythroid Parameters. Excess storage iron can occur in a large group of hematological diseases, collectively termed iron-loading anaemias, in which ineffective erythropoiesis or abnormalities of hemoglobin synthesis are prominent (1). They are characterized by anemia and a subsequent increase in iron absorption. Ultimately, the inefficient use of the iron leads to iron overload. To rule out the possibility that anemia could account for the abnormal iron storage defect demonstrated in [32m -/-mice, we determined several erythroid parameters. The results demonstrated that P, BC counts, Hb, HCT, and MCV values were even A B higher in the [32m -/-mice than in the other animal groups (Table 1) . Thus, the excess storage iron found in ~2m -/-mice could not be related to defective erythropoiesis or Hb synthesis.
Failure to Regulate Iron Absorption in ~2m -/-Mice.
One of the hallmarks of iron homeostasis is its exclusive regulation at the sites of absorption (28, 29) . The capacity to reduce or increase absorption of iron in response to increased or reduced iron stores is well documented. In HH, patients fail to decrease their iron absorption despite the accumulation of iron in the body (30) (31) (32) .
Iron retention, here defined as the percentage of 59Fe found in the body 7 d after the administration of an oral radioactive test dose, was plotted against iron concentration in livers (Fig. 4 A) . Despite the fact that J32m -/-mice have increased amounts of iron m livers when fed a standard diet, they did not downregulate their IR as compared to control B6 mice that were fed the same standard diet. Importantly, B6 rmce that were fed an iron-enriched diet promptly downregulated IR as a response to the modest increase of iron in their livers.
To test whether [32m -/-mice can downregulate iron absorption as a response to a similar overload induced by diet, iron retention was measured before and after feeding the animals with an iron-enriched diet for 14 d. Again, the downregulation of IR in response to moderately increased iron stores could readily be demonstrated in B6 and CD8 -/-mice. In marked contrast to the results observed in these 
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Data are presented as mean + SD. n, number of animals.
mice, ]32m -/-mice, even when challenged with high dietary iron, were unable to reduce their iron retention (Fig. 4/3) . A more specific indicator of the regulation of iron absorption is the so-called MT, here defined as the ratio of the iron ultimately retained in the body vs. the iron initially taken up by the gut mucosa. This is believed to be the critical step that is defective in HH patients (33) . We used a double-isotope technique (32; Santos, M., K.J.H. Wienk, M.W. Schillaam, H. Clevers, M. DeSousa, and J.J.M. Marx, manuscript in preparation) to discriminate between initial MU and subsequent iron retention, and hence calculate MT of iron. The MT in [32m -/-mice that were maintained on a standard diet was consistently higher than MT in normal or CD8 -/-mice ( Table 2 ). After experimental iron overload, MT in B6 and CD8 -/-mice was strongly reduced, whereas MT in [32m -/-mice was only mildly decreased (Fig. 4 C) .
Taken together, the capacity of [32m -/-mice to regulate iron absorption in response to changes in iron stores was strikingly affected at the level of the MT of iron to the plasma.
Fetal Liver Cell Transfer. As an alternative site for the primary iron handling defect in HH patients, the reticuloendothelial (RE) system has been proposed. Specifically, it has been shown that the RE cells in HH patients are impaired in their capacity to store iron (34) (35) (36) . A possible implication of these studies is that an abnormality in RE iron metabolism might affect the control of iron absorption by the intestinal mucosa (37) . We attempted to address this issue by reconstituting lethally irradiated [32m -/-mice with hematopoietic cells from normal mice. It was expected that if RE cells play a role in regulating iron absorption, [32m-/--reconstituted mice should be able to correct their abnormalities in iron homeostasis. All . Control B6 mace were maintained on a standard diet IR was measured at day 7 after the admamstration of the test dose. Mucosal transfer of iron was calculated from the ratio IR/MU. Individual values for each mouse are shown. MT was deterrmned as the ratio of IR/MU. Each mouse recmved orally a double ~sotope test dose containing SgFe and SlCr. MU was calculated 1 d later. 59Fe retention was determined by whole-body counnng 7 d after adn'nnistration of the test dose. Data are presented as mean -+ SD. n = number ofammals; P = Student's t test for comparison ofl32m -/ mice with B6 control and CD8 -/ mace.
tion was observed in [32m -/-mice at 1 (Fig. 5 B) and 2 mo (not shown) after reconstitution with B6 hematopoietic cells: the site of storage of excess iron shifted from parenchymal to Kupffer cells. Total liver iron concentrations, as measured by flame atomic absorption spectrometry, only showed a slight decrease (not shown). 3 mo after reconstitution, no stainable iron was observed in five out of seven treated mice (Fig. 5 D) . 
Discussion
Previously, we have reported the existence of hepatic iron overload in [32m -/-mice similar to that found in HH (11) . This was based on a histological and quantitative studies of the steady-state iron distribution and content in tissues of [B2m -/-mice. These results were confirmed more recently by others (13) . Now we report a detailed analysis of the nature of the iron metabolism defect of 132m -/-mice. These mice recapitulate all central features of HH; i.e., increased TS, visible iron depositions, specifically in parenchymal ceils of the liver, and a dysregulanon of intestinal iron absorption. The defect appears to be caused by the lack of a class I-like, 132m-dependent molecule, and not by the lack ofCD8 + T cells or TAP-dependent MHC molecules. Moreover, although the storage abnormalities in the liver of [32m -/-mice can be compensated by cell transfer, the increased intestinal iron absorption is not reduced by substitution of the hematopoietic compartment.
Intestinal Iron Absorption. The capacity of [32m /-mice to regulate intestinal iron absorption in the face of increased iron stores seems to be manifestly impaired. Similarly, in HH, patients fail to decrease their iron absorption despite the accumulation of iron in the body (30) (31) (32) .
Iron retention is only the ultimate result of the iron absorption process, which can be divided into two steps: MU from the intestinal lumen and the subsequent transfer of iron through mucosal cells into the blood. Under normal conditions, not all the iron is transferred into the circulation, but remains inside the mucosal cell and is rapidly lost after desquamation of the epithelial cells. MU is influenced by many intraluminal factors: the state of the iron in the test dose (ferric or ferrous, heme or nonheme), the amount of iron, the composition of the test dose, gastric and intestinal secretions, and the state of the brush border of the mucosal cells. The next step, MT, is less dependent on these intraluminal factors and will better reflect the iron status of the body. In [32m -/ mice, MT of iron into the plasma is invariably increased, even under normal dietary conditions. Importantly, MT is believed to be the critical step that is defective in HH patients (33) . Under increased iron loading, the differences between normal and [32m -/-mice become accentuated, as the [32m -/-mice fail to downregulate MT and iron retention.
Cellular Iron Storage. The parenchymal iron accumulation in the livers of[32m / mice resembles that of HH patients and contrasts with the histopathological findings in other iron storage disorders in man. The amount of demonstrable iron in macrophages in HH is minimal until the late stages of the disease (27, (39) (40) (41) (42) . By contrast, iron accumulation in the overload diseases Bantu siderosis (in Africa) and Kaschin-Beck (in Asia) is prominent both in mononuclear phagocyte system cells and in hepatic parenchymal cells (43) (44) (45) . The organ damage that occurs in HH patients subsequent to the iron accumulation (e.g., liver fibrosis, cirrhosis, hepatocellular carcinomas, and diabetic hyperglycemia caused by pancreatic islet destruction) also occurs in old [32m -/-mice (13, 46) .
The relevance of the observed iron storage abnormalities in [32m -/-mice emerges from numerous studies performed in animals in an attempt to mimic HH (47) (48) (49) (50) (51) . In these studies, excess dietary iron alone failed to produce the typical parenchymal iron accumulation and the resulting organ damage, even when iron concentrations in the liver were three to four times higher than the critical iron level associated with fibrosis in HH (52) . In accordance with these findings, we observed heavily iron-loaded macrophages in livers from control B6 mice after dietary manipulation. Apparently, surplus iron is redistributed from parenchymal cells to the mononuclear phagocyte system in liver of dietary iron-loaded animals (53) . This notion is consistent with previous studies that show a decreased iron storage capacity of macrophages in HH (35, 36, 54) . Similarly, it would appear that the Kupffer cells of 132m /-mice fall to store excess iron, even when surrounded by iron-loaded parenchymal cells. The apparent redistribution of stored iron from parenchymal to KuptTer cells upon transfer ofhematopoletlc ceils might suggest that [32m -/-Kupffer cells, like HH macrophages, carry an Intrinsic defect in iron storage.
Molecular Nature of the Defect.
[32m is required for the normal surface expression of classical and nonclassical MHC class I molecules (14, 15) . Thus, mice lacking a functional [32m gene fail to express MHC class I products (16, 17) , and consequently they lack CD8+ lymphocytes.
The TAP-1 and TAP-2 proteins are required for transport ofcytosolic peptides into the endoplasmatic reticulum for association with classical class I molecules (55) (56) (57) . TAP-1 mutant mice are deficient in peptide transport, and consequently do not express classical class I molecules on the surface of their cells (18) . Recently, it was shown that some nonclassical MHC I molecules may be expressed independently of TAP function (19, 20) . Livers from TAP1 -/ mice had normal iron concentration values, implying that classical MHC class I molecules are not responsible for the observed iron storage phenotype in [32m /-mice. Rather, it would appear that a "nonclassical," [32m-associated molecule performs a function in iron metabolism. Such a molecule would be dependent on the presence of [32m, but independent of TAP function.
The gene responsible for HH has been located on the short arm of chromosome 6, in linkage desequilibrium with the HLA-A locus (8, 58) , where several nonclassical MHC-I genes have been identified (59) (60) (61) . While this paper was under submission, a novel MHC class I-like gene, termed HLA-H, was reported to be mutated in a large majority of HH patients (62) . Two missense variants were found in 87% of HH patients. Importantly, the most preva-lent mutation was inferred to disrupt the putative [32m-binding site on the HLA-H molecule. The current data lend independent, functional support for a causative role of HLA-H mutations in HH.
Iron Homeostasis. One of the hallmarks of iron homeostasis is its exclusive regulation at the sites of absorption (28, 29) . It is not clear yet what mechanism regulates iron absorption from the gut, but two main hypotheses have been suggested from observations made in HH patients. One assumes a generalized defect in iron storage in the RE system and in the feedback regulation of iron absorption (37) . The other hypothesis assumes a direct role of the intestinal mucosal cells in regulating iron absorption (63) (64) (65) (66) (67) (68) .
Our results in the reconstituted [32m -/-mice supports the view that the primary iron metabolism defect is expressed both at the level of the gut epithelium and of Kupffer cells in the liver. The histopathological analysis indicated that the liver iron storage pattern was normahzed, indicating the involvement of hematopoietic-derived cells, Kupffer cells or others, in the regulation of cellular iron storage in the liver. However, the iron absorption defect of the mucosal intestinal cells could not be corrected by the transferred cells. The defect appears not to reside in the liver parenchyma. Consistent with this view is the observation that inadvertently transplanted livers from HH patients into recipients with otherwise normal iron metabolism returned to normal iron concentrations (69) (70) (71) . In these documented cases, a diseased liver was transplanted into recipients with normal hematopoietic compartment and gut mucosa. We propose that HLA-H is responsible for both primary metabolic defects in HH, namely the pattern of iron accumulation in the liver and the failure to regulate iron absorption.
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